Abstract:Background: The vast majority of women with dementia are post-menopausal. Despite clinical relevance, menopause is underrepresented in rodent models of dementia. Before menopause, women are less likely than men to experience strokes, obesity, and diabetes-known risk factors for vascular contributions to cognitive impairment and dementia (VCID). During menopause, ovarian estrogen production stops and the risk of developing these dementia risk factors spikes. Here, we aimed to determine if menopause worsens cognitive impairment in VCID. We hypothesized that menopause would cause metabolic dysfunction and increase cognitive impairment in a mouse model of VCID. Methods: We performed a unilateral common carotid artery occlusion surgery to produce chronic cerebral hypoperfusion and model VCID in mice. We used 4-vinylcyclohexene diepoxide to induce accelerated ovarian failure and model menopause. We evaluated cognitive impairment using behavioral tests including novel object recognition, Barnes maze, and nest building. To assess metabolic changes, we measured weight, adiposity, and glucose tolerance. We explored multiple aspects of brain pathology including cerebral hypoperfusion and white matter changes (commonly observed in VCID) as well as changes to estrogen receptor expression (which may mediate altered sensitivity to VCID pathology post-menopause). Results: Menopause increased weight gain, glucose intolerance, and visceral adiposity. VCID caused deficits in spatial memory regardless of menopausal status. Post-menopausal VCID specifically led to additional deficits in episodic-like memory and activities of daily living. Menopause did not alter resting cerebral blood flow on the cortical surface (assessed by laser speckle contrast imaging). In the white matter, menopause decreased myelin basic protein gene expression in the corpus callosum but did not lead to overt white matter damage (assessed by Luxol fast blue). Menopause did not significantly alter estrogen receptor expression (ERα, ERβ, or GPER1) in the cortex or hippocampus. Conclusions: Overall, we have found that the accelerated ovarian failure model of menopause caused metabolic impairment and cognitive deficits in a mouse model of VCID. Further studies are needed to identify the underlying mechanism. Importantly, the post-menopausal brain still expressed estrogen receptors at normal (pre-menopausal) levels. This is encouraging for any future studies attempting to reverse the effects of estrogen loss by activating brain estrogen receptors.

Endogenous Estrogens and Brain Activation During Verbal Memory Encoding and Recognition in the Postmenopause

Altered Spontaneous Brain Activity in Women During Menopause Transition and Its Association With Cognitive Function and Serum Estradiol Level

Menopause and Brain Health: Hormonal Changes Are Only Part of the Story

Estrogen, Cognitive Performance, and Functional Imaging Studies: What Are We Missing About Neuroprotection?

In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology

Within-person changes in reproductive hormones and cognition in the menopause transition

Estradiol associations with brain functional connectivity in postmenopausal women

Women’s Brain Health: Midlife Ovarian Removal Affects Associative Memory

Subcortical Volume Changes in Early Menopausal Women and Correlation With Neuropsychological Tests

A Case for Estradiol: Younger Brains in Women with Earlier Menarche and Later Menopause

Endogenous Estradiol and Testosterone Levels Are Associated with Cognitive Performance in Older Women and Men

Estrogen receptor α: a critical role in successful female cognitive aging

Cognitive effects of estradiol after menopause

Effect of estradiol with or without micronized progesterone on cholinergic-related cognitive performance in postmenopausal women

Linking alterations in estrogen receptor expression to memory deficits and depressive behavior in an ovariectomy mouse model

Higher Level of Circulating Estradiol is Associated with Lower Frequency of Cognitive Impairment in Southeast China

Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition

Associations of endogenous estrogens, plasma Alzheimer's disease biomarkers, and APOE4 carrier status on regional brain volumes in postmenopausal women

Estradiol and cognitive function: Past, present and future

Systematic review and meta-analysis of the effects of menopause hormone therapy on cognition

Menopause causes metabolic and cognitive impairments in a chronic cerebral hypoperfusion model of vascular contributions to cognitive impairment and dementia